{
    "2018-06-16": [
        [
            {
                "time": "",
                "original_text": "首款PD-1肺癌免疫药物7个月获批，美国一年疗售价百万",
                "features": {
                    "keywords": [
                        "PD-1",
                        "肺癌",
                        "免疫药物",
                        "获批",
                        "美国",
                        "疗售价",
                        "百万"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}